Cytokinetics ticker

Author: yqcx

August undefined, 2024

WebTicker CYTK. Exchange NASDAQ More. ... Cytokinetics is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions. Visit website. Social Media Links. Cytokinetics. Most Recent … WebApr 13, 2024 · Issuer Name and Ticker or Trading Symbol CYTOKINETICS INC [ CYTK] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director: 10% Owner: X: Officer (give title below) Other (specify below) EVP Research & Development: 3. Date of Earliest Transaction (Month/Day/Year)

Cytokinetics Announces Topline Results From METEORIC-HF

WebJul 19, 2024 · The data suggest that Cytokinetics (ticker: CYTK) drug could become a potent rival to a similar investigational drug that Bristol Myers Squibb (BMY) acquired last … WebApr 29, 2004 · Cytokinetics has raised a total of $1.1B in funding over 8 rounds. Their latest funding was raised on Jul 1, 2024 from a Post-IPO Debt round. Cytokinetics is … c scanf assignment

CYTK Cytokinetics Inc. Annual Income Statement MarketWatch

WebTicker: CYTK; CUSIP Number: 23282w605; Tip: Access positions for across all investors ... By clicking the button below, your credit card will be charged $28.00 USD (one time) and you'll have access to all Cytokinetics position data for 90 days. Purchase access * Investors with a full data subscription can access data for any fund and any ticker ... WebCytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential … WebCytokinetics, Incorporated CYTK: Raising target price to $38.00 CYTOKINETICS INC has an Investment Rating of HOLD; a target price of $38.000000; an Industry Subrating of … Find the latest Cytokinetics, Incorporated (CYTK) stock discussion in Yahoo … See the company profile for Cytokinetics, Incorporated (CYTK) including business … View the basic CYTK option chain and compare options of Cytokinetics, … SOUTH SAN FRANCISCO, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- … Discover historical prices for CYTK stock on Yahoo Finance. View daily, weekly or … At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio … Find out all the key statistics for Cytokinetics, Incorporated (CYTK), … Get the detailed quarterly/annual income statement for Cytokinetics, Incorporated … Find out the direct holders, institutional holders and mutual fund holders for … See Cytokinetics, Incorporated (CYTK) Environment, Social and Governance … c scanf 16進数

Cytokinetics, Incorporated (CYTK) - Stock Analysis

Cytokinetics ticker

Cytokinetics, Inc. (CYTK) Stock Price & News - Google Finance

WebFeb 28, 2024 · SOUTH SAN FRANCISCO, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food and Drug Administration (FDA) issued a Complete... WebNov 1, 2024 · SOUTH SAN FRANCISCO, Calif., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on October 29, 2024 it granted stock options to purchase an aggregate...

Did you know?

WebMar 6, 2024 · SOUTH SAN FRANCISCO, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the company is scheduled to participate in the following investor ... Web2 days ago · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators as potential …

WebDec 13, 2024 · PDUFA Target Action Date is February 28, 2024 Cytokinetics to Host Conference Call and Webcast on December 14, 2024 at 8:30 am Eastern Time SOUTH SAN FRANCISCO, Calif., Dec. 13, 2024 (GLOBE ... WebApr 7, 2024 · Cytokinetics, Inc.’s trailing 12-month revenue is $94.6 million with a -411.2% profit margin. Year-over-year quarterly sales growth most recently was -96.4%. Analysts expect adjusted earnings to reach $-4.363 per share for the current fiscal year. Cytokinetics, Inc. does not currently pay a dividend. The Biotechnology and Medical …

WebCytokinetics Stock Price Today NASDAQ CYTK Live Ticker - Investing.com Stock Screener United States Pre-Market World ADRs Stock Brokers Fed Rate Monitor Tool Cytokinetics Inc (CYTK)... WebCytokinetics is a Biotechnology Research, Drug Manufacturing & Research, and Biopharma company located in South San Francisco, California with $26.00 Million in revenue and 495 employees. Find top employees, contact details and business statistics at RocketReach. ... Ticker: CYTK Revenue: $26 million: Funding: $222.70 Million: …

Webwww.cytonics.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Biotechnology …

WebMar 1, 2024 · Cytokinetics Inc (CYTK) SEC Filing 8-K Material Event for the period ending Wednesday, March 1, 2024. Home. SEC Filings. Cytokinetics Inc (CYTK) 8-K Material Event Wed Mar 01 2024; SEC Filings. CYTK Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. Manager Portfolios. csc and topWebCytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential … c scanf and printfWebCytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) SOUTH SAN FRANCISCO, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, … dyschronometria treatmentWebFeb 28, 2024 · The US FDA has issued a Complete Response Letter to Cytokinetics ( NASDAQ: CYTK) for omecamtiv mecarbil for heart failure with reduced ejection fraction. Shares are down ~8% in post-market trading ... csc and intertrustWebBonnie Charpentier SVP Regulatory & Compliance at Cytokinetics, is currently unranked, see this insider's latest transactions. Top Stocks. Top Analyst Stocks Top Smart Score Stocks ... SVP Regulatory & Compliance at Cytokinetics, holds 0.00 shares in Cytokinetics (Ticker: CYTK). See the Hottest Stocks Based on Insider Trading > Bonnie ... c scanf a stringWebCytokinetics, Inc. (CYTK) Stock Price & News - Google Finance Markets +0.85 Home CYTK • NASDAQ Cytokinetics, Inc. Follow Share $35.84 Apr 3, 9:39:48 AM GMT-4 · … c scanf fehlerWebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Investors & Media Cytokinetics’ unparalleled expertise has … dyschronia chronos alternate trophy guide